ID
13048
Beschrijving
Low-dose IL-2 Plus IFN-alpha Immunotherapy as Adjuvant Treatment of Renal Carcinoma.; ODM derived from: https://clinicaltrials.gov/show/NCT00502034
Link
https://clinicaltrials.gov/show/NCT00502034
Trefwoorden
Versies (1)
- 13-01-16 13-01-16 -
Geüploaded op
13 januari 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Carcinoma, Renal Cell NCT00502034
Eligibility Carcinoma, Renal Cell NCT00502034
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
tumor diameter
Datatype
boolean
Alias
- UMLS CUI [1]
- C0475440
- UMLS CUI [2]
- C3272927
Beschrijving
chemotherapy, hormone therapy or immunotherapy
Datatype
boolean
Alias
- UMLS CUI [1]
- C0392920
- UMLS CUI [2]
- C0279025
- UMLS CUI [3]
- C0021083
Beschrijving
renal insufficiency, creatinine
Datatype
boolean
Alias
- UMLS CUI [1]
- C1565489
- UMLS CUI [2]
- C0201976
Beschrijving
arrhythmias, autoimmune diseases
Datatype
boolean
Alias
- UMLS CUI [1]
- C0003811
- UMLS CUI [2]
- C0004364
Similar models
Eligibility Carcinoma, Renal Cell NCT00502034
- StudyEvent: Eligibility
C0027695 (UMLS CUI [2])
C0027627 (UMLS CUI [2])
C3272927 (UMLS CUI [2])
C0279025 (UMLS CUI [2])
C0021083 (UMLS CUI [3])
C0201976 (UMLS CUI [2])
C0004364 (UMLS CUI [2])